Last reviewed · How we verify
NCT02984891
Optical Coherence Tomography (OCT) Intravascular Ultrasound (IVUS) Dual Imaging
trial testing Optical Coherence Tomography (OCT) in Coronary Artery Disease (CAD) in 7 participants. Terminated before completion.
27 June 2018
Quick facts
| Lead sponsor | Columbia University |
|---|---|
| Status | Terminated |
| Study type | OBSERVATIONAL |
| Enrollment | 7 |
| Start date | 6 October 2016 |
| Primary completion | 27 June 2018 |
| Estimated completion | 27 June 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Optical Coherence Tomography (OCT)
- Intravascular Ultrasound (IVUS)
Conditions studied
- Coronary Artery Disease (CAD) — all drugs for Coronary Artery Disease (CAD) →
Sponsor
Columbia University
Who can join
Eligibility, any sex, with Coronary Artery Disease (CAD). Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Both intravascular ultrasound (IVUS) and optical coherence tomography (OCT) are standardly used and have been extensively studied separately to guide percutaneous coronary intervention and improve long-term outcomes. In this study, the investigators aim to directly compare high-definition IVUS images to OCT in the same patients to determine the differences between each modality as they relate to imaging coronary pathology, with the goal of determining which modality is most appropriate in particular clinical scenarios.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT02984891
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Optical Coherence Tomography (OCT)
Trials testing the same drug.
- NCT07434362 — Serum Endocan, Alarin, and Galanin-Like Peptide Levels in Diabetic Retinopathy · NA · completed
- NCT06976034 — oCular Examination at Cell RESolution With Optical TransmissionTomography · NA · recruiting
- NCT04510727 — Optical Coherence Tomography Guided C&D · NA · withdrawn
- NCT05161546 — Study of Bipolar Disorders and Retinal Electrophysiological Markers · NA · terminated
- NCT04774822 — Validation Study of RETINA-AI Galaxy™, an Automated Diabetic Retinopathy Screening Device · completed
Other recruiting trials for Coronary Artery Disease (CAD)
Currently open trials in the same condition.
- NCT07479433 — The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI · recruiting
- NCT07349875 — Colchicine Treatment for Non-Flow-Limiting Coronary Plaque by Coronary CTA: A Randomized Controlled Trial · Phase 4 · recruiting
- NCT07277686 — AI Facial Analysis Algorithm to Screening Coronary Artery Disease in High-Risk Community Population · recruiting
- NCT07148518 — Comparison of Upper and Lower Limb Maximal Exercise Capacities and Arterial Stiffness in Patients With CAD · recruiting
- NCT07392021 — Effects of a Recovery-Promoting Program in Patients Undergoing CABG Surgery · NA · active not recruiting
Other Columbia University trials
Trials by the same sponsor.
- NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
- NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
- NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
- NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
- NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT02984891 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Columbia University
- Last refreshed: 18 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02984891.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing